Back
Protara Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
25
TARA
Protara Therapeutics
Last Price:
$2.82
Seasonality Move:
-15.89%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TARA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Protara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.91 | Sell |
| 20-day SMA: | 3.06 | Sell |
| 50-day SMA: | 3.25 | Sell |
| 200-day SMA: | 3.57 | Sell |
| 8-day EMA: | 2.91 | Sell |
| 20-day EMA: | 3.02 | Sell |
| 50-day EMA: | 3.27 | Sell |
| 200-day EMA: | 3.48 | Sell |
Protara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 43.4 | Sell |
| Chaikin Money Flow: | 66828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.92 - 3.26) | Sell |
| Bollinger Bands (100): | (3.13 - 4.21) | Sell |
Protara Therapeutics Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protara Therapeutics Stock
Is Protara Therapeutics Stock a Buy?
-
Protara Therapeutics share price is 2.89 while TARA 8-day simple moving average is 2.91, which is a Sell signal.
-
The stock price of TARA is 2.89 while Protara Therapeutics 20-day SMA is 3.06, which makes it a Sell.
-
Protara Therapeutics 50-day simple moving average is 3.25 while TARA share price is 2.89, making it a Sell technically.
-
TARA stock price is 2.89 and Protara Therapeutics 200-day simple moving average is 3.57, creating a Sell signal.
TARA Technical Analysis vs Fundamental Analysis
Sell
25
Protara Therapeutics (TARA)
is a Sell
Is Protara Therapeutics a Buy or a Sell?
-
Protara Therapeutics stock is rated a SellThe current Protara Therapeutics [TARA] share price is $2.89. The Score for TARA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Protara Therapeutics Stock Info
Market Cap:
111.5M
Price in USD:
2.89
Share Volume:
133.7K
Protara Therapeutics 52-Week Range
52-Week High:
10.48
52-Week Low:
1.60
Sell
25
Protara Therapeutics (TARA)
is a Sell
Protara Therapeutics Share Price Forecast
-
What is the Protara Therapeutics stock price today?The Protara Therapeutics stock price is 2.89 USD today.
-
Will TARA stock go up or go down?Protara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protara Therapeutics is overvalued.
Is Protara Therapeutics Stock a Buy?
-
Protara Therapeutics share price is 2.89 while TARA 8-day exponential moving average is 2.91, which is a Sell signal.
-
The stock price of TARA is 2.89 while Protara Therapeutics 20-day EMA is 3.02, which makes it a Sell.
-
Protara Therapeutics 50-day exponential moving average is 3.27 while TARA share price is 2.89, making it a Sell technically.
-
TARA stock price is 2.89 and Protara Therapeutics 200-day simple moving average is 3.48, creating a Sell signal.
Fundamental Analysis of Protara Therapeutics
Is Protara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.54 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Protara Therapeutics
Should I short Protara Therapeutics stock?
-
TARA Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Protara Therapeutics is a Sell
-
Protara Therapeutics Relative Strength Index (RSI) is 43.4, which suggest Protara Therapeutics is oversold
-
The Bollinger Bands (25) for Protara Therapeutics is (2.92 - 3.26), which suggest Protara Therapeutics is a Sell
-
The Bollinger Bands (100) for Protara Therapeutics is (3.13 - 4.21), which suggest Protara Therapeutics is a Sell
* Protara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.